← Back to Search

Behavioral Intervention

Standard smoking cessation counseling for Nicotine Addiction

N/A

Waitlist Available

Led By James Loughead, Ph.D.

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Treatment-seeking smokers between the ages of 18 and 65, reporting consumption of at least 5 cigarettes per day for at least the past 6 months

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months after target quit date

Awards & highlights

Study Summary

This trial will look at how changes to the brain caused by giving up smoking contribute to whether or not somebody is able to stay smoke-free.

Who is the study for?

This trial is for smokers aged 18-65 who smoke at least 5 cigarettes daily for the past 6 months, plan to stay local for 3+ months, and can consent in English. Excluded are those using other cessation programs, heavy drinkers, drug users, pregnant/breastfeeding women, certain mental health conditions or medications that affect safety.Check my eligibility

What is being tested?

The study tests how quitting smoking affects brain changes by providing standard smoking cessation counseling to participants seeking treatment. It aims to understand the neural mechanisms behind the risk of relapse during abstinence.See study design

What are the potential side effects?

Since this trial involves counseling rather than medication or medical procedures, there are no direct side effects from interventions. However, participants may experience withdrawal symptoms typical of smoking cessation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a smoker aged 18-65 and smoke at least 5 cigarettes daily for the past 6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months after target quit date

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months after target quit date

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after target quit date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Days to relapse

Secondary outcome measures

Mood

Nicotine withdrawal

Smoking Urges/Craving

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Standard smoking cessation counselingExperimental Treatment1 Intervention

Participants will receive a standard treatment program consisting of smoking cessation counseling.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Standard smoking cessation counseling

2016

N/A

~280

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,879,838 Total Patients Enrolled

7 Trials studying Nicotine Addiction

1,705 Patients Enrolled for Nicotine Addiction

James Loughead, Ph.D.Principal InvestigatorUniversity of Pennsylvania

2 Previous Clinical Trials

278 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current openings for participation in this research project?

"Evidently, this clinical trial is not currently accepting patients. The first posting of the study was on May 1st 2016 and its final update occurred on July 6th 2022. However, there are 1192 other medical trials actively recruiting right now."

Answered by AI

Is admission to this investigation open at present?

"Prerequisites for entry into this trial include a recent relapse and age between 18 and 65. The medical team aim to recruit 250 participants in total."

Answered by AI

Does the study open its doors to participants of septuagenarian age?

"To apply for this study, a person must be between 18 and 65. For those below the age of consent there are 171 studies available, while 1019 clinical trials exist for people above the elderly threshold."

Answered by AI